| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 214.962 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 120.383 | 78 |
| GSM780709 | Untreated after 4 days (C3_1) | 121.194 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 177.004 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 143.428 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 126.182 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 316.865 | 88 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 116.531 | 77 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 811.792 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 352.724 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 124.223 | 78 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 916.54 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 69.7277 | 69 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 158.474 | 81 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 108.9 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 74.6626 | 70 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 164.911 | 81 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 104.894 | 76 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 87.8596 | 73 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 79.8334 | 72 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 118.937 | 78 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 94.3671 | 74 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 105.816 | 76 |